Header Logo

Connection

Jacob Rotmensch to Sesquiterpenes

Back to Details
This is a "connection" page, showing publications Jacob Rotmensch has written about Sesquiterpenes.
Jacob Rotmensch
Connection Strength
0.088
Sesquiterpenes
  1. A phase 2 evaluation of irofulven as second-line treatment of recurrent or persistent intermediately platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group trial. Int J Gynecol Cancer. 2010 Oct; 20(7):1137-41.
    View in: PubMed
    Score: 0.088
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.